For decades, physicians have known that about half of all patients with heart failure appear to have hearts that contract normally—a syndrome now known as heart […]
On 30 December, a month after licensing the Pfizer BioNTech covid-19 vaccine, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) revised its guidance to enable […]
Appleby asks whether covid-19 vaccines would be considered cost effective using the National Institute for Health and Care Excellence (NICE) approach to measuring value—and questions whether […]